Men and osteoporosis by Diamond, T. et al.
Deakin Research Online 
Deakin University’s institutional research repository 
DDeakin Research Online  
Research Online  
This is the published version (version of record) of: 
 
Diamond, T., Sambrook, P., Williamson, M., Flicker, L., Nowson, Caryl, 
Fiatarone-Singh, M., Lord, S., Ferris, L., O`Neil, S. and MacLennan, A. 
2001-08, Men and osteoporosis, Australian family physician, vol. 30, no. 
8, pp. 781-785. 
 





Copyright to Australian Family Physician. Reproduced with 
permission. Permission to reproduce must be sought from the 
publisher, The Royal Australian College of General Practitioners. 
 










Copyright ofFull Text rests with the original
copyright owner and, except as permitted under the
Copyright Act 1968, copying this copyright material
is prohibited without the permission of the owner or
its exclusive licensee or agentor by way of a licence
from Copyright Agency limited. For infonnation
about such licences contact Copyright Agency
Limited on (02) 93947600 (Ph) or (02) 93947601 ----f--------------------,(fax)-- - - - - ----
BACKGROUND Wliil!: strict criteria huvc Ilt~(~11 d(~\'(~I()Jl(~d for ddillillg osteoporosis in women (hone
miuurul d(~Il!,ilY meusurements more titan 2.;') srundurd deviutirms hcluw the mean for young adult
uurmul W(lI]}CH" ic. r-srorc vuluc <-2.S) ', there still rcmuius a ccunrovcrsv regarding the definition iu ureu.
~piJlal [ructnru..., OCt:1I1" ill :)(XI 1I11d hip fnH:lllrl'S ill (;(1.1 of men older thun SO years. There lire sigllifit:alll
difkn'lll'(':' Iwt\\":(~11 men aile! wnmeu with respc...t 10 [he jl<ll!logeIH:sis of O~lP()porosis. IIJ1(lprl~'iJlg medical
roudition-, i111(11)(htrrilctUI'C . .,eq"d;j(~.
OBJECTIVE To !lrl)\'ilk uu on~rvil'w or the PlldlOgl~llt',..,i,.." diagll(j~is and prevention or o~tl'0I'0I'(Jsi-; ill
1111'11.
DISCUSSION OS1('0Jlorosi,~ is incn'llsillgly 1'I~('Ogllisl'll. Dntu Ircun thc Duhlm ()sll'Olllll'usis Epidcllliology
Stlldy Sllt!gl',-;l..., thur :HjIXl of IIH~II ill Ausrruliu llg('d over (){) vcnrs "'ill suffer from <Ill oStl~op0l'(Jlic
Iru.uurc. Ir i-, c-riuuucd [hal :)()-(t()lXI of men pn'sl'lltillg \\',itll spinal Iructures will havl: another illness
runu-iluuiug to their 1)(1111; I(l.-',~, O:'II'OpOl'olic fructurc- ill men are assOI:i<lted with !ligIH~r rum-hiditv and
1l1oI'I1lJit~· 1111111 ill women. Likstyle dWllc:C" logl:lher with daily culciutu supplomcntntiun shuuld l)(~
implemented <\lid viuuniu D:.{ shollid II(' considered ill 11lCJl wilh ostcopcnia.
Terry Diamond, MB, BCh MRCP, FRACP, is Associate Professor of Clinical Medicine, University of New
South Wales, St George Hospital, New South Wales. Philip Sambrook, MBBS, LLB, FRACP, is Professor
of Rheumatology, Royal North Shore Hospital, New South Wales. Margaret Williamson, MBChB,
MRCP, FRACP, is an Endocrinologist, St Andrews Hospital, Brisbane, Queensland. leon Flicker, MBBS,
CDipEpid, PhD, FRACP, is Professor, Geriatric Medicine, Royal Perth Hospital- Western Australia. Caryl
Nowson, PhD, BSc, is Senior Lecturer, School of Health Sciences, Deakin University, Victoria. Maria
Fiatarone-Singh, MO, FRACP, is Professor, John Sutton Chair of Exercise and Sport Science, University of
Sydney, New South Wales. Stephen lord, BSc, MA, PhD, is Research Fellow, Prince of Wales Medical
Research tnstitute, New South Wales. Linda Ferris, MBBS, BSc (Med), FRACP, is Director of Orthopaedics
endTrsums, Madbury Public Teaching Hospital and Senior Clinical Lecturer, University of Adelaide,
South Australia. Sheila O'Neil. MBBCh, BAO, MICGP, is Clinical Director, Centre for Aging in Women,
Brisbane, Queensland. Alistair Maclennan, MBChB, MD,-FROG,- FRANZCOG,-KAssociateProfessor,
Department of Obstetrics and GynaecoJogy, Adelaide University, South Australia.
Osteoporosis is increasingly recog-nised in men.!" It is estimated that
19% of men older than 50 years will have
osteoporosis. Spinalfractures occur in 5%
of men (comparedto 16% of women) and
hip fractures in 6% of men (compared to
18% of women) older than 50 years.'
Data from the Dubbo Osteoporosis
Epidemiology Study suggests that 30% of
men in Australia aged over 60 years will
suffer from an osteoporoticfracture.'
Today the life expectancy for men has
increased to a mean age of 76.8 years,
With men now living longer, they can be
expected to develop multiple coexisting
illnesses contributing to bone loss, and an
increased .likelihood of falling and
fragility fractures.v" 11 is estimated that
30-60% of men presenting with spinal
fractures have another illness contribut-
ing to their bone disease>' The presence
of a prevalent spinal fracture increases
the risk of future spinal fraclures by as
much as 10-25 times, depending on the
subject's age and the presence of osteo-
porosis as defined by bone mineral
density."
The impact of osteoporosis on individ-
ual men and the community is dramatic.
The morbidity and mortality afIer hip
fracture is higher in men than in women
with 20.7% of men compared to 7.5% of
women over 75 years dying after a hip
fracture! Mortality in men five years afIer
hip or spinal fracture is about 20% in
excess of that expected! The physical
functioning significantly deteriorates in
elderly men after hip fracture, withone in
five requiring a higher level of long term
care. The postfracture outcome and prog-
nosis in men appears to be significantly
influenced by their pre-existing medical
illnesses (cornorbidities).' In Australia in
1995, the financial burden attributed to
hip fracture aione in men was
$110 million. This estimate did not
include the costs associated with loss of
qualityof life."
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• Men and osteoporosis
Table 1. Factors associated
with increased risk of
osteoporosis
• Family history
Medical conditions (Table 2)




• Lifestyle factors including smoking,
high alcohol intake
• Physical inactivity
Table 2. Medical conditions associated with osteoporosis
• Prolonged glucocorticoid therapy (see guidelines on the management of
glucocorticoid induced osteoporosis)
• Conditions associated with excess glucocorticoid secretion (Cushing syndrome)
• Primary (testicular failure/orchidectomy) or secondary (hypothalamic pituitary
disorders) hypogoria-disiii~-inciuding·-a-ntic.:aridrogens (combined androgen
blockade for prostate cancer)
• Post-transplantation
• Chronic cardiopulmonary disorders (congestive heart failure, emphysema/chronic
bronchitis, bronchiectasis, cystic fibrosis)
• Chronic neuromuscular disorders (Parkinsonism)
Malabsorption, hepatobiliary, coeliac and chronic inflammatory bowel diseases
• Rheumatological disorders (rheumatoid arthritis, ankylosing spondylitis)




• Anticonvulsant therapy (Dilantin)
• Chronic depresston
What causes bone loss in
men?
Bone loss occurs with ageing in both men
and women. In elderly men, this occurs
predominantly as a result of decreased
bone formation with minimal increases in
bone resorption." On bone histornor-
phometry, this is manifestedby trabecular
plate thinning and endocortical bone
resorption." Recent data suggests that a
reduction in periosteal bone formation
may also contribute to a smaller bone size
(reduced vertebral body and femoral
neck width) leading to an increased frac-
ture risk." Longitudinal studies suggest
that bone loss in elderly men is approxi-
mately 5-10% per decade, with bone loss
further acceleratingafter 75 years of age."
Other factors contributing to age related
-ocme 16ss-incluQ~·1i~~---- ._. _. -,- ,
• physical immobility
• poor nutrition
• reduced calcium absorption (low
calcium dietary intakes and diminished
intestinalabsorption)
• vitamin D deficiency
• increasedparathyroid hormone
activity
• reduced cytokineand growth factors,
(suchas insulingrowth factor I)
• reduced osteoblastic activity and
recruitment
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Men and osteoporosis •
ised using software derived from refer-
ence databases for 'healthy' Australian
men aged 20-40 years.
Diagnosis
Both age and BMD are strong predictors
of fracture rates and survival.":"
Unfortunately'risk-factors -alone-have -a
low sensitivity and specificity in predict-
ing hip fractures (59.6% and 61%,
respectively)."Bone mineral density mea-
surements therefore remain the gold
standard for assessing the severity of
osteoporosis and fracture risk. The crite-
ria for diagnosing osteoporosis in women
is based on the World Health
Organisation recommendation of using a
BMD value of more than 2.5 standard
deviations below the young normal mean
reference range (t-score <-2.5). These
criteria, however, have not been stan-
dardised in men. Until a final consensus is
reached, the diagnosis of osteoporosis in
men should use a similar t-score value
«_2.5)Y·1L44 To permit more accurate
t-score calculations in individual men.
bone densitometers should be standard-
tional delay in puberty have significantly
reduced spinal and forearm bone mineral
density (BMD)." At least 60% of men
presenting with osteoporosis have a sec-
ondary cause (Table 2).' The remainder Interpreting the BMD
have no identifiable medical conditionsor . - The interpretation of BMD in men needs
risk factors associated with bone loss and special attention. Advanced spondy-
are referred to as having primary or idio- loarthropathy, facet joint disease and
pathic osteoporosis. aortic calcification may falsely elevate
A recent study has demonstrated that spinal BMD as assessed by dual energy
men with medical disorders associated X-ray absorptiometry (DXA)."~' Bone
with osteoporosis had a twofold increase mineral density reports usually include the
in the risk of hip fractures (OR=2.9; mean value for the combined L2-L4 verte-
1.3-4.3), while conditions linked with an brae. In cases where BMD values are
increased risk of falling were associated pseudo-elevated, the LJ, L2 and L3 verte-
with an almost sevenfold increase in risk brae may need to be analysed separately.
(OR=6.9; 3.3-14.8)." These factors Spinal X-rays are required to assess for
together accounted for almost 72% of the presence of extravertebral calcification
the hip fractures in men. Other signifi- and asymptomatic spinalfractures (usually
cant risk factors contributing to hip defined as greater than 20% red~ction of
fracture in men include comorbid factors the anterior, posterior or central vertebral
(such as sleep disturbance, impaired height). Quantitative computed tomogra-
mental status and poor appetite), previ- phy (QCT) of the lumbar spine is another
ous stroke with hemiplegia, prior option for measuring spinal bone mass."
fragility fractures, senile dementia. alco- This technique has the abilityto accurately
holism and gastrectomy." define a region of interest not confounded
by extravertebral calcification. It is limited,
however, by a highprecision error (greater
than 3-4%) which may render it unsuit-
able for monitoring changes and also has
the potential of an increased radiation
exposure.
Femoral neck DXA may therefore be
more appropriate for diagnosing osteo-
porosis and for monitoring bone mass in
elderly men in whom pseudo-elevations
in BMD are evident. In a recent study the
relative risk of hip fracture in men was 3.0
(1.7-5.4) for each standard deviation
decrease in femoral neck BMD.~
While men are more susceptible to
traumatic fractures, it remains imperative
to measure BMD in all men who have:
• radiologicalevidence of bone derniner-
alisation
• significant risk factors or
• aged over 50 years with a history of an
atraumatic fracture.
A Medicare rebate is available for bone
densitometry in these-subjects.
Testosterone and osteoporosis
While serum testosterone levels decline
with age, this hormone accounts for only
5% of the age and weight adjusted vari-
ance in bone loss. re An accelerated phase
of bone loss similar to that seen in
menopausal women hasbeen described in
men with hypogonadism secondary to
gonadectomy or androgen de pr iva-
tion.20.2l>-2S The classic histomorphometric
findings accompanying this disorder
includes osteoclast activation associated
with trabecular plate perforation and loss
of trabecular connectivity." Partial
reversibility of the bone loss has been
reported following androgen
replacement":" or antiresorptive therapy
(calcitonin> or bisphosphonates":"].
The biological significance of testes-
terone levels just below or in the
low-normal reference range in elderlymen
remains controversial."> Hypogonadism
per se, with serum testosterone levels in
the 'castrate' range, is a major risk factor
for osteoporosis.t-":" However, the fact
that testosterone therapy alone does not
restore bone mass in hypogonadal men
suggests that other hormonal factors may
be important in the pathogenesis of hypog-
onadal bone loss."?' The recent discovery
of a mutation in thearomatase receptor in
an osteoporotic man has led to advances in




• a failure to achieve a peak bone mass
and/or
• secondary causes of bone loss
(Tables 1.2).
Compared with women, little attention
has been paid to the determinants of peak
bone mass in men, which include racial,
genetic, nutritional, hormonal, medical
and lifestyle factors.' Puberty has been
shown to be a major determinant
accounting for at least 40% of peak bone
mass acquired between the ages of 9-13
ycars."-" Men with a history of constitu-
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Prevention of osteoporosis
Effective antifracture therapies for men
presenting with osteoporosis are limited.
It is therefore essential to consider pre-
ventative measures in.men at high risk
(Table 1) or with BMD t-score values
equal or less than -1.0. General practi-
tioners play an important role in not only
identifying patients who are at risk, but
also in educating patients in lifestyle
changes to reduce this risk. Although
medical intervention may be required in
some individuals. patients should be
informed of the importance of maximis-
ing peak bone mass in childhood and
adolescence. as well as maintaining a
stable bone mass throughout adult life.
Smoking should be avoided and alcohol
intake limited. Any reversible medical
factors should be treated (Table2).
Diet and supplements
A diet consisting of adequate general
nutrition, calcium and vitamin D is espe-
cially important in elderly patients.?" The
National Institute of Health consensus
statement" outlines the recommended
calcium requirements for men (1500 mg
daily). Calcium rich foods, and especially
---dairy-products such as milk, ice cream,
cheese and yogurt are readily absorbed.
Vitamin D plays an important role in
maintaining skeletal integrity and pre-
venting hip fractures." Vitamin D2 is only
present in minimal amounts in the diet.
Cholecalciferol (vitamin D3) is predomi-
nantly formed by the action of ultraviolet
radiation on the skin. Vitamin D3 is
metabolised in the liver and in the kidney.
to active metabolites responsible for pro-
moting intestinal calcium absorption, and
thereby reducing negative calcium
balance. Both ageing and the use of sun-
block creams limit the ability of the skin
to make vitamin D. Chronic liver and
renal diseases inhibit the hydroxylation of
vitamin D3. Nutritional supplementation
is therefore necessary for those individu-
als at risk of vitamin D deficiency, usually
with serum 25 hydroxyvitamin D below
40 nmol/l). These include:
• the chronically ill,
• frail and elderly patients
• patients with chronic hepatobiliary
disorders. and
• those treated with anti-epilepticmed-
ications.?
Simple vitamin D3 is available in
Australia as ergocalciferol (Ostelin 1000
lU per capsule). Weight loss and low
intakes of energy and protein also result
in osteopenia and should be avoided in
nonobese individuals."
Exercise
Regular weight bearing exercise (this
would include ball sports, walking.
running. hiking, aerobics etc.) should be
encouraged in children and adolescents."
High impact activities (such as jumping
and running) have a greater effect on
maintaining bone than low impact activi-
ties. Activities which do not involve
supporting the body weight against
gravity (swimming and cycling) are less
effective.
Conclusion
Osteoporosis is a significant problem,
affecting 19% of men over 50.
Osteoporotic fractures have a high mor-
bidity in men and result in mortality 20%
greater than expected for age. Men pre-
senting with spinal fractures frequently
have an underlying medical condition
contributing to their bone loss. It is there-
fore essential to identify and treat these
medical conditions so as to reduce the
fracture risk. Patients with primary or
idiopathic osteoporosis need to be identi-
fied and treated with both lifestyle
intervention programs in addition to anti-
osteoporotic therapies.
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SUMMARY OF
IMPORTANT POINTS
• Osteoporotic fractures affect up to
60% of women and 30% of men
aged over 60 years.
• Osteoporotic fractures in men are
associated with a poor outcome, a
greater than 20% excess in
mortality than expected and a
considerable cost to the
community.
• All men 50 years and older
presenting with a fracture should
be considered as having
osteoporosis and should undergo
bone densitometry.
• Exercise is important. The benefits
obtained may extend beyond
osteoporosis to include other age
related conditions such as
hypertension, heart disease,
diabetes, arthritis etc.
• The-cause of osteoporosis in men
should always be defined and
specific disease processes should
be treated appropriately.
• While primary prevention of
fractures remains crucial,
treatment to ensure that further





Prichard Wing, Gray Street
Kogarah, NSW 2217
Email: terrydiamond@optushome.com.au
References are available for this article.
Email afp@racgp.org.au or phone 03
92141546.
Australian FamilyPhysicianVol. 30. No.8, August 2001 • 785
